Cargando...

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates

PURPOSE: Within the last decade, SurePath and ThinPrep [both liquid-based cytology (LBC) tests] have replaced conventional cytology (CC) as primary test method in cervical cancer screening programs of multiple countries. The aim of our study was to examine the effect in the Dutch screening program....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Causes Control
Main Authors: Rozemeijer, Kirsten, Penning, Corine, Siebers, Albert G., Naber, Steffie K., Matthijsse, Suzette M., van Ballegooijen, Marjolein, van Kemenade, Folkert J., de Kok, Inge M. C. M.
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4703623/
https://ncbi.nlm.nih.gov/pubmed/26458884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10552-015-0678-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!